Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
23 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-to-present-latest-clinical-results-from-two-studies-in-cpi-resistant-solid-tumors-at-asco-2025-302463999.html
21 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-enters-into-a-global-clinical-collaboration-with-msd-to-evaluate-atg-022-cldn18-2-adc-in-combination-with-keytruda-pembrolizumab-302460200.html
25 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-presents-four-posters-at-aacr-2025-highlighting-focuses-on-antengagertm-tces-and-synthetic-lethality-302438082.html
23 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-to-present-latest-results-from-two-clinical-studies-at-asco-2025-302436703.html
26 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-to-present-results-from-four-cutting-edge-preclinical-studies-at-aacr-2025-with-focuses-including-antengagertm-tces-and-synthetic-lethality-302411814.html
21 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/antengene-announces-2024-full-year-financial-results-proprietary-programs-advancing-to-pivotal-trials-with-accelerating-multi-market-revenue-ramp-up-302407888.html
ABOUT THIS PAGE